Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Emphysema Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Emphysema Drugmarket, defines the market attractiveness level of Emphysema Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Emphysema Drug industry, describes the types of Emphysema Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Emphysema Drug market and the development prospects and opportunities of Emphysema Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Emphysema Drug market in Chapter 13.
By Player:
Angion Biomedica Corp
SATT North SAS
TGV-Laboratories
rEVO Biologics, Inc
ProMetic Life Sciences Inc
By Type:
BB-3
EDO-66
MG-53
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Emphysema Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Emphysema Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Emphysema Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Emphysema Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Emphysema Drug Market Analysis and Outlook to 2022
-
7.1 Global Emphysema Drug Consumption (2017-2022)
-
7.2 United States Emphysema Drug Consumption (2017-2022)
-
7.3 Europe Emphysema Drug Consumption (2017-2022)
-
7.4 China Emphysema Drug Consumption (2017-2022)
-
7.5 Japan Emphysema Drug Consumption (2017-2022)
-
7.6 India Emphysema Drug Consumption (2017-2022)
-
7.7 South Korea Emphysema Drug Consumption (2017-2022)
8 Region and Country-wise Emphysema Drug Market Analysis and Outlook to 2028
-
8.1 Global Emphysema Drug Consumption Forecast (2022-2028)
-
8.2 United States Emphysema Drug Consumption Forecast (2022-2028)
-
8.3 Europe Emphysema Drug Consumption Forecast (2022-2028)
-
8.4 China Emphysema Drug Consumption Forecast (2022-2028)
-
8.5 Japan Emphysema Drug Consumption Forecast (2022-2028)
-
8.6 India Emphysema Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Emphysema Drug Consumption Forecast (2022-2028)
9 Global Emphysema Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Emphysema Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global BB-3 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global EDO-66 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global MG-53 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Emphysema Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Emphysema Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Emphysema Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global BB-3 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global EDO-66 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global MG-53 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Emphysema Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Emphysema Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Emphysema Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Emphysema Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Emphysema Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Emphysema Drug Market Competitive Analysis
-
14.1 Angion Biomedica Corp
-
14.1.1 Angion Biomedica Corp Company Details
-
14.1.2 Angion Biomedica Corp Emphysema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Angion Biomedica Corp Emphysema Drug Product and Service
-
14.2 SATT North SAS
-
14.2.1 SATT North SAS Company Details
-
14.2.2 SATT North SAS Emphysema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 SATT North SAS Emphysema Drug Product and Service
-
14.3 TGV-Laboratories
-
14.3.1 TGV-Laboratories Company Details
-
14.3.2 TGV-Laboratories Emphysema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 TGV-Laboratories Emphysema Drug Product and Service
-
14.4 rEVO Biologics, Inc
-
14.4.1 rEVO Biologics, Inc Company Details
-
14.4.2 rEVO Biologics, Inc Emphysema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 rEVO Biologics, Inc Emphysema Drug Product and Service
-
14.5 ProMetic Life Sciences Inc
-
14.5.1 ProMetic Life Sciences Inc Company Details
-
14.5.2 ProMetic Life Sciences Inc Emphysema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 ProMetic Life Sciences Inc Emphysema Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Emphysema Drug
-
Figure Emphysema Drug Picture
-
Table Global Emphysema Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Emphysema Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Emphysema Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Emphysema Drug Consumption by Country (2017-2022)
-
Figure United States Emphysema Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Emphysema Drug Consumption and Growth Rate (2017-2022)
-
Figure China Emphysema Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Emphysema Drug Consumption and Growth Rate (2017-2022)
-
Figure India Emphysema Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Emphysema Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Emphysema Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Emphysema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Emphysema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Emphysema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Emphysema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Emphysema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Emphysema Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BB-3 Consumption and Growth Rate (2017-2022)
-
Figure Global EDO-66 Consumption and Growth Rate (2017-2022)
-
Figure Global MG-53 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global BB-3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global EDO-66 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MG-53 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Emphysema Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Emphysema Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Angion Biomedica Corp (Foundation Year, Company Profile and etc.)
-
Table Angion Biomedica Corp Emphysema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Angion Biomedica Corp Emphysema Drug Product and Service
-
Table SATT North SAS (Foundation Year, Company Profile and etc.)
-
Table SATT North SAS Emphysema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table SATT North SAS Emphysema Drug Product and Service
-
Table TGV-Laboratories (Foundation Year, Company Profile and etc.)
-
Table TGV-Laboratories Emphysema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table TGV-Laboratories Emphysema Drug Product and Service
-
Table rEVO Biologics, Inc (Foundation Year, Company Profile and etc.)
-
Table rEVO Biologics, Inc Emphysema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table rEVO Biologics, Inc Emphysema Drug Product and Service
-
Table ProMetic Life Sciences Inc (Foundation Year, Company Profile and etc.)
-
Table ProMetic Life Sciences Inc Emphysema Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ProMetic Life Sciences Inc Emphysema Drug Product and Service
-
